Loading...
•
Sep 30, 2021
DexCom Q3 2021 Earnings Report
Dexcom's revenue increased by 30% year-over-year, driven by volume growth and new customer additions. The company raised its full-year revenue and margin guidance.
Key Takeaways
Dexcom reported a strong third quarter with revenue growth of 30% year-over-year to $650.2 million. The company's GAAP operating income was $118.3 million, or 18.2% of revenue. Dexcom also raised its full-year revenue and margin guidance.
Revenue grew 30% versus the same quarter of the prior year to $650.2 million.
U.S. revenue growth of 23% and international revenue growth of 57%.
GAAP operating income of $118.3 million or 18.2% of revenue.
Completed the acquisition of our distributor in Australia and New Zealand.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Dexcom is increasing its guidance for fiscal year 2021 revenue, Non-GAAP gross profit margin, Non-GAAP operating margin, and Adjusted EBITDA margin.
Positive Outlook
- Revenue of approximately $2.425 - 2.450 billion (26-27% growth; Growth includes approximately 1% from acquired revenue in conjunction with Dexcom’s acquisition of its distributor in Australia and New Zealand)
- Non-GAAP Gross Profit Margin of approximately 68%
- Non-GAAP Operating Margin of approximately 16%
- Adjusted EBITDA Margin of approximately 25%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...